Yuliya Weissman

Dr. Yuliya Weissman

Institute of personalized cardiology, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
GVG. O. Veliev
G. O. Veliev
YWYuliya Weissman
Yuliya Weissman
IPI. V. Patchenskaya
I. V. Patchenskaya
MPM. G. Poltavskaya
M. G. Poltavskaya
Aim To compare effects of neuromuscular electrostimulation (NMES) with various intensity of induced muscle contractions on its tolerance and effect on physical work ability in elderly patients admitted for chronic heart failure (CHF). Material and methods The study included 22 patients older than 60 years admitted for decompensated CHF. NMES was performed from the 2nd or 3d day of stay in the hospital to the discharge from the hospital. Patients choose the stimulation regimen themselves based on the result of the first session: the high intensity to achieve maximum tolerable muscle contractions (group 1) or the lower intensity to achieve visible/ palpable muscle contractions (group 2). Prior to the onset and after the completion of the training, the 6-min walk test (6MWT) was performed and the general condition of the patient was assessed with a visual analogue scale (VAS). Results More patients, mostly women, chose the less intensive NMES (14 vs. 8). The groups did not differ in age, comorbidity, and functional condition. Both groups achieved considerable increases in the 6MWT distance (7.3 [5.6; 176] and 9.8 [7.0; 9.9] %, respectively, p>0.05) and VAS scores without a significant difference between the groups. Among the patients who were compliant with continuing NMES after the discharge from the hospital, 69% were patients of the group of the less intensive stimulation. Conclusion The less intensive NMES (with achieving visible muscle contractions) was characterized by better tolerance and better compliance in elderly patients with decompensated CHF compared to the more intensive NMES (with achieving maximum contractions), but the less intensive NMES was not inferior to the more intensive NMES in effectiveness.

Verified
Journal Article
Open access
PDF file
ABAzamat Baymukanov
Azamat Baymukanov
YWYuliya Weissman
Yuliya Weissman
IBIrina Andreevna Bulavina
Irina Andreevna Bulavina
IIIlya Leonidovich Ilyich
Ilya Leonidovich Ilyich
STSergey Arturovich Termosesov
Sergey Arturovich Termosesov
Introduction: Obstructive sleep apnea (OSA) is associated with an increased risk of hypertension, coronary artery disease, heart failure (HF), and atrial fibrillation (AF). Materials and methods: A total of 179 patients aged 34–81 years were included in the study. The median age was 63 years (interquartile range: 56–69 years). Of these patients, 105 (58.7%) were men, and 74 (41.3%) were women; there were cases of paroxysmal (n = 99), persistent (n = 64), and permanent AF (n = 16). All patients underwent investigations including respiratory sleep monitoring, echocardiography, and 24 h Holter electrocardiography monitoring. Statistical analyses were performed using IBM SPSS Statistics 26.0. Results: OSA was detected in 131 (73.2%) patients. In patients with OSA, paroxysmal AF was commonest (n = 65), followed by persistent AF (n = 51) and permanent AF (n = 15). The patients with sleep apnea had increased body mass index (33.6 kg/m2; p = 0.02), waist circumference (114 cm; p < 0.001), and neck circumference (42 cm; p < 0.001) values. HF (OR 2.9; 95% CI: 1.4–5.9; p = 0.004) and type 2 diabetes (OR 3.6; 95% CI: 1.5–8.3; p = 0.001) were more common in patients with AF and OSA. The STOP-BANG scale (AUC = 0.706 ± 0.044; 95% CI: 0.619–0.792; p < 0.001) and the Berlin questionnaire (AUC = 0.699 ± 0.044; 95% CI: 0.614–0.785) had a higher predictive ability for identifying sleep apnea. Conclusions: Patients with AF demonstrate a high prevalence of OSA and an increased association with cardiovascular comorbidities. The STOP-BANG scale and the Berlin questionnaire can be used to screen for OSA in patients with AF.

17 February 2025 in Russian Medicine
Verified
Journal Article
Closed access
MYMaria V. Yunyaeva
Maria V. Yunyaeva
IBIrina Andreevna Bulavina
Irina Andreevna Bulavina
ABAzamat Baymukanov
Azamat Baymukanov
YWYuliya Weissman
Yuliya Weissman
AEArtem Anatolyevich Evmenenko
Artem Anatolyevich Evmenenko
ВДВайсман Юлия Дмитриевна
Вайсман Юлия Дмитриевна
BACKGROUND: Obstructive sleep apnea (OSA) is associated with various cardiovascular diseases, including arterial hypertension, chronic heart failure, and cardiac rhythm and conduction disorders. In some patients, preexisting bradycardia may not be directly related to OSA. Therefore, it is advisable to rule out OSA in patients referred for pacemaker implantation. CLINICAL CASES DESCRIPTION: OSA is a common condition frequently associated with bradyarrhythmias. In some cases, treatment for such patients involves the implantation of a permanent endocardial pacemaker. Undiagnosed OSA may lead to an increased number of unnecessary pacemaker implantations, emphasizing the importance of timely diagnosis and treatment of this condition. This article presents clinical observations of seven patients with nocturnal bradyarrhythmias, which resolved following continuous positive airway pressure (CPAP) therapy. The use of CPAP therapy contributed to the improvement of cardiovascular parameters, including the reduction in the number and duration of heart rhythm pauses. Clinically significant bradyarrhythmias were resolved in patients, allowing them to avoid surgical intervention. In the described cases, patients demonstrated a high apnea–hypopnea index (35.0–79.5 episodes per hour), a significant decrease in blood oxygen saturation (minimum up to 50%), and significant heart rhythm disturbances during the night. The initiation of CPAP therapy led to a reduction in the apnea–hypopnea index (1.9–23.1 episodes per hour), normalization of minimum oxygen saturation (80–93%), and the elimination of prolonged rhythm pauses. CONCLUSION: The findings highlight the necessity of mandatory screening for OSA in patients with nocturnal bradyarrhythmias before planning pacemaker implantation. CPAP therapy effectively eliminates rhythm disturbances associated with sleep apnea and prevents unnecessary surgical procedures. This confirms the importance of a comprehensive approach to the diagnosis and treatment of this category of patients and the need for further large-scale studies to optimize their management tactics.

20 November 2025 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Closed access
ABAzamat Baymukanov
Azamat Baymukanov
YWYuliya Weissman
Yuliya Weissman
EKE. I. Kotlyarevskaya
E. I. Kotlyarevskaya
AMA. V. Melekhov
A. V. Melekhov
Transthyretin (ATTR) amyloidosis is a progressive disease that can present as isolated cardiac involvement or as a combination with systemic manifestations, including polyneuropathy, gastrointestinal tract disorders, and ophthalmopathy. The disease is associated with the deposition of unstable breakdown products of transthyretin tetramers, a plasma protein responsible for transporting thyroxine and retinol. ATTR is most commonly hereditary (ATTRm/ATTRv), caused by mutations in the transthyretin gene, but it can also occur in an acquired, non-hereditary “wild-type” form (ATTRwt), which develops in older adults. Cardiac involvement in ATTR amyloidosis resembles hypertrophic or restrictive cardiomyopathy, manifesting as symptoms of heart failure, rhythm disorders, and conduction abnormalities. Diagnosis is challenging due to the rarity of the disease, nonspecific symptoms, and the difficulties of performing endomyocardial biopsy. The verification of the diagnosis increasingly relies on modern imaging methods such as gadolinium-enhanced magnetic resonance imaging and technetium-99m pyrophosphate myocardial scintigraphy. The presented clinical case describes a 56-year-old patient with amyloid cardiomyopathy, which manifested as a combination of progressive rhythm and conduction disturbances (atrial fibrillation, trifascicular block, pauses up to 4,7 seconds, and runs of ventricular tachycardia) against the background of gradually decreasing left ventricular ejection fraction and marked diastolic dysfunction. These clinical syndromes necessitated the exclusion of secondary causes of myocardial involvement. The diagnosis was confirmed without biopsy – through the use of modern imaging techniques, including contrast-enhanced cardiac MRI and 99mTc-pyrophosphate scintigraphy, in accordance with current recommendations. This case illustrates the possibility of early detection and successful treatment of ATTRwt amyloidosis using advanced diagnostic methods in real-world clinical practice. These methods help refine the disease’s prevalence, improve diagnostic accuracy, and ensure timely treatment, significantly influencing the prognosis and quality of life.

15 January 2025 in The Clinician
Verified
Journal Article
Open access
PDF file
YWYuliya Weissman
Yuliya Weissman
ABAzamat Baymukanov
Azamat Baymukanov
AEA. A. Evmenenko
A. A. Evmenenko
IBI. A. Bulavina
I. A. Bulavina
MYM. V. Yunyaeva
M. V. Yunyaeva
ЮВЮ. Д. Вайсман
Ю. Д. Вайсман
Aim. To compare patients with bradyarrhythmias and obstructive sleep apnea (OSA) and patients without OSA; to study the predictive capabilities of questionnaires in OSA screening.Material and methods. The study included 134 patients with bradyarrhythmias hospitalized for pacemaker implantation or pacemaker replacement. The median age was 67.5 years (interquartile range 59 to 72 years). Sleep apnea screening was performed using the Berlin questionnaire, the STOP-BANG sleep apnea risk scale, and the Epworth sleepiness scale. All patients underwent blood tests and instrumental examinations (respiratory monitoring and echocardiography).Results. Patients with OSA were older (68 years versus 64 years; p = 0.032), had a larger waist circumference (116 cm versus 108 cm; p = 0.044), and body mass index (33.7 kg/m2 versus 31.03 kg/m2; p = 0.016) compared to patients without OSA. The Berlin questionnaire (area under the curve (AUC) 0.79; sensitivity 92 %, specificity 38 %; p 0.0001) and the STOP-BANG risk scale (AUC 0.75; sensitivity 82 %, specificity 23 %; p 0.0001) had a high predictive power to identify sleep apnea while the Epworth sleepiness scale had a low predictive power (AUC 0.463; sensitivity 12 %, specificity 85 %). According to laboratory and instrumental data, patients with sleep apnea had significantly higher C-reactive protein levels (7.17 mg/L versus 1.73 mg/L; p = 0.012) and more frequently had interventricular septal hypertrophy (12 mm versus 10 mm; p = 0.02). Third-degree atrioventricular block was significantly more common in patients with sleep apnea (17.91 % versus 5.97 %; odds ratio 0.363; 95 % confidence interval 0.131–1.001; p = 0.045). In patients with sleep apnea, cardiac pacing for more than 5 years was more common (11.94 % versus 4.48 %; odds ratio 0.35; 95 % confidence interval 0.116–1.054; p = 0.049).Conclusion. High frequency of OSA was observed in patients with bradysystolic heart rate. The Berlin questionnaire and the STOP-BANG sleep apnea risk scale can be used to screen for OSA in patients with bradyarrhythmias. Elevated C-reactive protein levels and interventricular septal hypertrophy accentuate the importance of early diagnosis and treatment of OSA for improved prognosis.